LOS ANGELES, March 18, 2014 /PRNewswire/ -- Verde Media
Group Inc. (OTC:VMGI) through its Verde Media Biotechnology
Division ("VMBD") announces the addition of cutting edge microbial
technology program to produce cannabis-based phytocannabinoids
products, including delta-9 tetrahydrocannabinol (THC) and
cannabidiol (CBD). The VMBD team will use the tool of
metabolic engineering to transfer cannabis genetic pathways in
microbes representing an alternative route to produce cannabinoids
at an affordable and scalable manner.
The wide spread use of cannabis based medicines in diseases such
as multiple sclerosis, chronic pain and many others requires large
scale production of cannabinoids. VMBD and its novel approach will
complement traditional greenhouse based production of plant
material for rapid commercialization of active and derivative
chemicals for both medical and recreational use. Furthermore,
microbial based cannabinoids are uniform and specific in
composition which is critical in medicinal usage and overcomes
diverse pharmacological activities otherwise associated with
different varieties or strains of plant materials.
Dr. Abidi, Ph.D. CEO of VMBD stated, "The microbial technology
to produce key active cannabinoid molecules adds to our growing
platform technologies for mass production and extraction of
marijuana oils. We believe the alternative microbial production
route can reduce THC/CBD cost by ten times or more, adding to our
competitive advantage in the industry. Our deep domain expertise in
metabolic engineering and purification will allow rapid
commercialization of cannabinoid based products in a fast growing
market."
About Verde Media Group Inc.
Verde Media Group Inc. is a publicly traded company listed on
the OTC Markets trading under the stock symbol: VMGI. Verde
Media Group Inc. The company is consists of three
divisions:
Agency Division- The innovative Agency division services-
public relations, marketing, and transaction functions for
corporate clientele. The agency is rapidly expanding its
business in the Denver, Colorado
market that will become the largest retail marijuana sector
currently legitimized.
BioTech Division- The VMBD division undertakes the business of
developing and producing high value bio-products from renewable
biomass. The focus and criterion is to develop proprietary
microbial technologies with low risk scale-up methods employing low
cost feedstock. VMBD will further develop the derivative and
ester forms of THC for increase potency and their use in different
delivery systems, including sublingual, inhaled dosage forms and
blending with food products.
Entertainment Division- The company operates a managed
media company with production, distribution, development, and
acquisition functions for film and television.
For more information, visit www.verdemediagroup.com, or connect
with the company on Facebook. Twitter- @Verdemediagroup
DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING
STATEMENTS
The results described herein cannot be guaranteed. This release
contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Statements in this news release other than statements of historical
fact are "forward-looking statements" that are based on current
expectations and assumptions.
Logo -
http://photos.prnewswire.com/prnh/20140219/PH68218LOGO
SOURCE Verde Media Group Inc.